Strong sales and earnings increase in the first half-year 2023

Donaueschingen, 15 August 2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by approx. 12% and EBT by 23% in the first six months of 2023. As a result, the continually positive development of sales and earnings of the last years could be continued.

Sales improved from KEUR 100,032 to KEUR 111,842 (+11.8%) in the first half-year 2023. The international share of total business volume was 47.9% (6M-2022: 47.5%) and amounted to KEUR 53,516 compared to KEUR 47,488 (6M-2022).

The consolidated earnings before taxes (EBT) rose very sharply by 23.2% to KEUR 14,729 (6M-2022: KEUR 11,956), and consolidated surplus rose by 17.3% to KEUR 10,734 (6M-2022:
9,151 KEUR): EBIT increased by 12.0% from KEUR 12,403 (6M-2022) to KEUR 13,888, and EBITDA increased by 7.0% to KEUR 22,276 (6M-2022: KEUR 20,823).

Operating cash amounted to KEUR 25,460 in the first six months (6M-2022: KEUR 29,666) and remains at a very high level.

As of 30/06/2023, the company had cash resources at its disposal in the amount of KEUR 113,198 (31/12/2022: KEUR 110,019).

The half-year figures include sales from company acquisitions in the current year 2023 amounting to KEUR 798. The EBT was affected with TEUR 1,045.

Nexus AG had equity capital amounting to KEUR 245,180 as of 30/06/2023 (31/12/2022: KEUR 238,946). Consequently, the equity capital rate is 65.2% (31/12/2022: 69.4%).

This demonstrates that Nexus AG has a sustainable and healthy balance sheet as well as sufficient capital for further financing of its European growth strategy.

 

You might also be interested in

    • NEXUS-Gruppe

    VERY STRONG REVENUES AND EARNINGS INCREASE IN 2022

    Donaueschingen, 07/03/2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its revenues by 11.1% and EBIT by 15.2% in the fiscal year 2022. As a result, the continually positive development of revenues and earnings of the last two decades could be continued.

    • NEXUS-Gruppe

    VERY STRONG SALES AND EARNINGS INCREASE IN THE FIRST QUARTER 2023

    Donaueschingen, 16/05/2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 11% and EBIT by approx. 28% in the first three months of 2023. As a result, the continually positive development of sales and earnings of the last years could be continued.

    • NEXUS-Gruppe

    Very strong sales and earnings increase in the third quarter 2023

    Donaueschingen, 07/11/2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 14% and EBT by approx. 33% in the first nine months of 2023. As a result, the continually positive development of sales and earnings of the last years could be continued.

Do you need help? We are happy to advise you.
Contact Mail
X
Lightbulb
What are you looking for? Fachbereiche, Experten, Behandlungsschwerpunkte und Standorte
Nicht das gewünschte Ergebnis? Nutzen Sie die globale Suche. Zur Suche